2022
DOI: 10.1038/s41398-022-01978-y
|View full text |Cite
|
Sign up to set email alerts
|

Depression history modulates effects of subthalamic nucleus topography on neuropsychological outcomes of deep brain stimulation for Parkinson’s disease

Abstract: Patients with psychiatric symptoms, such as depression, anxiety, and visual hallucinations, may be at increased risk for adverse effects following deep brain stimulation of the subthalamic nucleus for Parkinson’s disease, but there have been relatively few studies of associations between locations of chronic stimulation and neuropsychological outcomes. We sought to determine whether psychiatric history modulates associations between stimulation location within the subthalamic nucleus and postoperative affectiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 73 publications
0
1
0
Order By: Relevance
“…In particular, the evolution of dopaminergic and serotonergic dysfunction and abnormalities of limbic circuits across time, involving the orbitofrontal and anterior cingulate cortices, ventral striatum, amygdala, thalamus, and other important brain networks, help to delineate the variable expression and severity of depression in patients with preclinical/prodromal, early and advances stages of PD (Prange et al 2022 ). A history of depression may also be an increased risk of adverse effects following subthalamic nucleus deep brain stimulation (Kratter et al 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…In particular, the evolution of dopaminergic and serotonergic dysfunction and abnormalities of limbic circuits across time, involving the orbitofrontal and anterior cingulate cortices, ventral striatum, amygdala, thalamus, and other important brain networks, help to delineate the variable expression and severity of depression in patients with preclinical/prodromal, early and advances stages of PD (Prange et al 2022 ). A history of depression may also be an increased risk of adverse effects following subthalamic nucleus deep brain stimulation (Kratter et al 2020 ).…”
Section: Discussionmentioning
confidence: 99%